Castleark Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.01M | Buy |
250,430
+13,340
| +6% | +$480K | 0.27% | 51 |
|
|
2025
Q1 | $9.35M | Buy |
237,090
+25,720
| +12% | +$1.01M | 0.32% | 41 |
|
|
2024
Q4 | $6.36M | Buy |
211,370
+42,560
| +25% | +$1.28M | 0.22% | 110 |
|
|
2024
Q3 | $3.95M | Buy |
+168,810
| New | +$3.95M | 0.16% | 138 |
|
|
2023
Q3 | – | Sell |
-90,980
| Closed | -$2.26M | – | 312 |
|
|
2023
Q2 | $2.26M | Buy |
+90,980
| New | +$2.26M | 0.1% | 158 |
|
|
2021
Q4 | – | Sell |
-20,211
| Closed | -$673K | – | 363 |
|
|
2021
Q3 | $673K | Sell |
20,211
-186,550
| -90% | -$6.21M | 0.03% | 236 |
|
|
2021
Q2 | $8.02M | Sell |
206,761
-10,870
| -5% | -$422K | 0.27% | 102 |
|
|
2021
Q1 | $10.5M | Buy |
217,631
+65,715
| +43% | +$3.17M | 0.38% | 81 |
|
|
2020
Q4 | $7.9M | Buy |
151,916
+26,706
| +21% | +$1.39M | 0.3% | 88 |
|
|
2020
Q3 | $3.35M | Buy |
+125,210
| New | +$3.35M | 0.13% | 149 |
|